
OPKO Health OPK
$ 1.17
0.0%
Quarterly report 2025-Q2
added 07-31-2025
OPKO Health P/S Ratio 2011-2026 | OPK
Annual P/S Ratio OPKO Health
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.61 | 4.09 | 0.816 | 1.14 | 2.41 | 0.977 | 2.13 | 2.4 | 3.48 | 8.18 | 55.7 | 30 | 40.7 | 52.2 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 55.7 | 0.816 | 15.1 |
P/S Ratio of other stocks in the Diagnostics research industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
1.72 | - | -6.23 % | $ 30.6 M | ||
|
Burning Rock Biotech Limited
BNR
|
6.87 | $ 19.89 | 10.93 % | $ 211 M | ||
|
Agilent Technologies
A
|
6.64 | $ 120.39 | 2.46 % | $ 36.6 B | ||
|
Aspira Women's Health
AWH
|
5.55 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
0.229 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
0.254 | - | 0.22 % | $ 16.8 M | ||
|
CareDx, Inc
CDNA
|
2.61 | $ 17.63 | 4.75 % | $ 939 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
5.71 | - | - | $ 562 M | ||
|
DermTech
DMTK
|
2.77 | - | -11.32 % | $ 2.94 M | ||
|
Akumin
AKU
|
0.1 | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
0.0018 | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
9.4 | $ 1.38 | -4.83 % | $ 1.84 M | ||
|
Exact Sciences Corporation
EXAS
|
6 | - | - | $ 19.8 B | ||
|
Accelerate Diagnostics
AXDX
|
13.5 | - | -61.36 % | $ 2.46 M | ||
|
Castle Biosciences
CSTL
|
2.14 | $ 24.37 | 3.57 % | $ 677 M | ||
|
Global Cord Blood Corporation
CO
|
0.196 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
3.48 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
1.36 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
2.9 | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
1.92 | $ 179.31 | 0.54 % | $ 8.89 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
2.47 | - | - | $ 10.7 B | ||
|
Interpace Biosciences
IDXG
|
0.19 | $ 2.2 | - | $ 9.73 M | ||
|
Danaher Corporation
DHR
|
6.09 | $ 198.61 | 1.4 % | $ 142 B | ||
|
Heska Corporation
HSKA
|
3.28 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
0.469 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
3.75 | $ 130.32 | 2.65 % | $ 20.7 B | ||
|
Medpace Holdings
MEDP
|
5.12 | $ 520.0 | 3.74 % | $ 15 B | ||
|
Fulgent Genetics
FLGT
|
1.65 | $ 16.02 | 4.71 % | $ 484 M | ||
|
Koninklijke Philips N.V.
PHG
|
1.8 | $ 29.09 | 1.89 % | $ 20 B | ||
|
Motus GI Holdings
MOTS
|
3.1 | - | -34.28 % | $ 263 K | ||
|
Guardant Health
GH
|
13.7 | $ 86.4 | 5.1 % | $ 10.8 B | ||
|
QIAGEN N.V.
QGEN
|
5.03 | - | - | $ 10.6 B | ||
|
Myriad Genetics
MYGN
|
0.496 | $ 4.91 | 6.97 % | $ 455 M | ||
|
Anixa Biosciences
ANIX
|
0.718 | $ 2.88 | 1.05 % | $ 93.5 K | ||
|
Biomerica
BMRA
|
1.35 | $ 2.1 | 0.96 % | $ 4.82 M | ||
|
Senseonics Holdings
SENS
|
9.94 | $ 6.75 | 0.45 % | $ 282 M | ||
|
ICON Public Limited Company
ICLR
|
3.25 | $ 113.06 | 2.44 % | $ 9.33 B | ||
|
NeoGenomics
NEO
|
2.04 | $ 8.35 | 4.38 % | $ 1.07 B | ||
|
Laboratory Corporation of America Holdings
LH
|
1.71 | $ 268.87 | 1.78 % | $ 22.4 B | ||
|
Neogen Corporation
NEOG
|
1.14 | $ 9.61 | 5.14 % | $ 2.08 B | ||
|
Lantheus Holdings
LNTH
|
3.32 | $ 82.74 | 1.31 % | $ 5.58 B | ||
|
Quest Diagnostics Incorporated
DGX
|
2.11 | $ 194.16 | 0.65 % | $ 21.6 B | ||
|
Natera
NTRA
|
6.47 | $ 214.64 | 6.31 % | $ 21.1 B | ||
|
ENDRA Life Sciences
NDRA
|
1.59 K | $ 4.96 | -4.43 % | $ 3.9 M | ||
|
Invitae Corporation
NVTA
|
4.18 | - | - | $ 21.2 M | ||
|
National Research Corporation
NRC
|
2.29 | $ 17.04 | 1.34 % | $ 381 M | ||
|
Organovo Holdings
ONVO
|
21.5 | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
1.76 | - | -16.95 % | $ 1.54 M |